Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.80
Bid: 67.00
Ask: 68.60
Change: -0.40 (-0.59%)
Spread: 1.60 (2.388%)
Open: 68.20
High: 68.20
Low: 67.60
Prev. Close: 67.80
CCEP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

12 Mar 2021 17:31

RNS Number : 1167S
Coca-Cola European Partners plc
12 March 2021
 

COCA-COLA EUROPEAN PARTNERS PLC FILES INTEGRATED REPORT AND FORM 20-F

LONDON, 12 March 2021 - Coca-Cola European Partners plc ("CCEP") (ticker symbol CCEP) announces that, on 12 March 2021, it filed its 2020 Integrated Report and Form 20-F with the Securities and Exchange Commission. This document was filed in accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual and includes CCEP's audited results for the year ended 31 December 2020. The unaudited fourth-quarter and full year results for the period ended 31 December 2020 were released on 11 February 2021.

The 2020 Integrated Report and Form 20-F is available on CCEP's website at https://ir.cocacolaep.com/financial-reports-and-results/integrated-reports and also online at www.sec.gov.

A copy of the 2020 Integrated Report and Form 20-F will be available shortly at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Pursuant to Disclosure Guidance and Transparency Rule 6.3.5R, a summary of the principal risks and uncertainties, information regarding related party transactions and a responsibility statement are set out in the Appendices. Page references included in this announcement refer to page numbers in the 2020 Integrated Report and Form 20-F. References to notes to the financial statements refer to notes in the 2020 Integrated Report and Form 20-F. This announcement should be read with, and is not a substitute for reading, the full 2020 Integrated Report and Form 20-F.

CONTACTS

Company Secretariat

Clare Wardle

T +44 20 7355 8406

Investor Relations

Sarah Willett

+44 7970 145 218

Media Relations

Shanna Wendt

T +44 7976 595 168

 

ABOUT CCEP

Coca-Cola European Partners plc is a leading consumer goods company in Western Europe, making, selling & distributing an extensive range of non-alcoholic ready to drink beverages & is the world's largest Coca-Cola bottler based on revenue. Coca-Cola European Partners serves a consumer population of over 300 million across Western Europe, including Andorra, Belgium, continental France, Germany, Great Britain, Iceland, Luxembourg, Monaco, the Netherlands, Norway, Portugal, Spain & Sweden. The Company is listed on Euronext Amsterdam, the New York Stock Exchange, London Stock Exchange & on the Spanish Stock Exchanges, trading under the symbol CCEP.

For more information about CCEP, please visit www.cocacolaep.com & follow CCEP on Twitter at @CocaColaEP.

 

 

APPENDIX A - PRINCIPAL RISKS AND UNCERTAINTIES

Our approach to risk

Our decisions are informed by an understanding of the risks we face as a business. Through our enterprise wide risk management programme, we identify, measure and manage risk, and embed a strong risk culture across our business.

CCEP's risk management framework looks at both risks we face and how we capitalise on opportunities we have.

Since the creation of CCEP, we have continually matured our risk management capabilities through seamless collaboration across the business. This has resulted in the creation of the one risk office, which helps us to manage risks and respond rapidly through established processes like incident management, business continuity plans and risk transfer mechanisms.

During the COVID-19 pandemic, the framework allowed us to respond rapidly to a fast changing environment. As a result, we were able to capture learnings and developed a comprehensive pandemic handbook that allowed us to respond well to the second wave and ensure that the impacts from COVID-19 were minimised. We are leveraging learnings from the current situation to further strengthen our risk management framework and prepare ourselves even better for future challenges.

The risk and internal control systems have continually improved since CCEP was created and are developed to address the changing risk environment and to adopt best practice in how to manage them.

Measuring and managing risk

The Directors have carried out a robust assessment of these principal risks.

The following is a summary of the Group's Principal Risks that are included in the 2020 Integrated Report and Form 20-F, however, this summary is not intended to include all risks that could ultimately impact our business and is presented in no particular order:

· Business continuity and resilience

· Packaging

· Cyber and social engineering attacks and IT infrastructure

· Economic and political conditions

· Market

· Legal, regulatory and tax change

· Climate change and water

· Perceived health impact of our beverages and ingredients, and changing consumer buying trends

· Competitiveness, business transformation and integration

· People and wellbeing

· Relationships with The Coca-Cola Company and other franchisors

· Product quality

For further details about our principal risks and uncertainties please refer to pages 44 to 50 of the 2020 Integrated Report and Form 20-F.

APPENDIX B - RELATED PARTY TRANSACTIONS

Details regarding related party transactions can be found in Note 19 of the Notes to the Consolidated Financial Statements on pages 160 to 162 of the 2020 Integrated Report and Form 20-F.

APPENDIX C - DIRECTORS' RESPONSIBILITIES STATEMENT

(page 111 of the 2020 Integrated Report and Form 20-F)

Responsibility for preparing financial statements

The Directors are responsible for preparing the Integrated Report and the financial statements in accordance with applicable United Kingdom (UK) law and regulations.

UK company law requires the Directors to prepare financial statements for each financial year. Under that law, the Directors have prepared group and parent company financial statements in accordance with international accounting standards, in conformity with the Companies Act 2006 (Companies Act). They have elected to prepare the parent company financial statements in accordance with International Financial Reporting Standards (IFRS) in conformity with the Companies Act. Under the Disclosure Guidance and Transparency Rules, group financial statements are required to be prepared in accordance with IFRS adopted pursuant to Regulation (EC) No 1606/2002 as it applies in the European Union.

Under section 393 of the Companies Act, the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the Group and of the profit or loss of the Company and of the Group for that period.

In preparing the Company financial statements, the Directors are required to:

· Select suitable accounting policies and apply them consistently

· Make judgements and accounting estimates that are reasonable and prudent

· Follow applicable international accounting standards in conformity with the requirements of the Companies Act (except where any departures from this requirement are explained in the notes to the company financial statements)

· Prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business

In preparing the Group financial statements the Directors are required to:

· Select suitable accounting policies and apply them consistently

· State whether international accounting standards in conformity with the requirements of the Companies Act (and IFRS adopted pursuant to Regulation (EC) No 1606/2002 as it applies in the European Union) have been followed, subject to any material departures disclosed and explained in the financial statements

· Present information, including accounting policies, in a manner that provides relevant, reliable, comparable and understandable information

· Provide additional disclosures when compliance with the specific requirements in IFRS are insufficient to enable users to understand the impact of particular transactions, other events and conditions on the entity's financial performance

· Make an assessment of the Group's ability to continue as a going concern

The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act. They are responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

They are also responsible for the maintenance and integrity of the corporate and financial information included on the Company's website.

Legislation, regulation and practice in the UK governing the preparation and dissemination of financial statements may differ from legislation, regulation and practice in other jurisdictions.

Responsibility statement

The Directors, whose names and functions are set out on pages 66-70, confirm that to the best of their knowledge:

· The consolidated financial statements, prepared in accordance with international accounting standards in conformity with the requirements of the Companies Act (and IFRS adopted pursuant to Regulation(EC) No 1606/2002 as it applies in the European Union) give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation taken as a whole

· The management report includes a fair review of the development and performance of the business and the position of the Company and the undertakings included in the consolidation taken as a whole, together with a description of the principal risks and uncertainties they face

· The Integrated Report and financial statements, taken as a whole, are fair, balanced and understandable and provide the information necessary for shareholders to assess the Company's position and performance, business model and strategy

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSSFEFFEEFSESD
Date   Source Headline
21st Jul 20232:30 pmRNSDirector/PDMR Shareholding
13th Jul 20233:30 pmRNSDirector/PDMR Shareholding
30th Jun 20234:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20233:00 pmRNSDirector/PDMR Shareholding
8th Jun 202310:50 amRNSDirector/PDMR Shareholding
1st Jun 20232:15 pmRNSTotal Voting Rights
26th May 20234:30 pmRNSDirector/PDMR Shareholding
25th May 202311:30 amRNSResult of AGM
23rd May 20233:00 pmRNSDirector/PDMR Shareholding
18th May 202311:30 amRNSDirector/PDMR Shareholding
15th May 20233:30 pmRNSLetter to Shareholders
4th May 20234:00 pmRNSDirector/PDMR Shareholding
2nd May 20232:45 pmRNSTotal Voting Rights
25th Apr 20237:00 amRNSQ1 Trading Update & Interim Dividend Declaration
21st Apr 20234:58 pmRNSDirector/PDMR Shareholding
14th Apr 20231:30 pmRNSDirector/PDMR Shareholding
12th Apr 20239:00 amRNSNotice of AGM
3rd Apr 20232:45 pmRNSTotal Voting Rights
22nd Mar 202311:45 amRNSDirector/PDMR Shareholding
22nd Mar 202311:45 amRNSDirector/PDMR Shareholding
17th Mar 20233:30 pmRNSBlock listing Interim Review
17th Mar 202311:55 amRNSAnnual Financial Report
14th Mar 20239:45 amRNSDirector/PDMR Shareholding
13th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20233:50 pmRNSDirector/PDMR Shareholding
1st Mar 20233:20 pmRNSTotal Voting Rights
23rd Feb 202310:30 amRNSDirector/PDMR Shareholding
16th Feb 20237:00 amRNSPreliminary Unaudited Results Q4 & FY 2022
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 202310:00 amRNSDirectorate Change
1st Feb 20233:30 pmRNSTotal Voting Rights
23rd Jan 20234:30 pmRNSDirector/PDMR Shareholding
16th Jan 20232:30 pmRNSDirector/PDMR Shareholding
3rd Jan 20232:40 pmRNSTotal Voting Rights
21st Dec 20223:45 pmRNSDirector/PDMR Shareholding
1st Dec 20223:15 pmRNSTotal Voting Rights
23rd Nov 20228:00 amRNSDirector/PDMR Shareholding
15th Nov 20225:30 pmRNSDirector/PDMR Shareholding
4th Nov 20225:20 pmRNSDirector/PDMR Shareholding
2nd Nov 20227:00 amRNSQ3, Investor Event & Interim Dividend Declaration
1st Nov 20223:45 pmRNSTotal Voting Rights
21st Oct 20223:00 pmRNSDirector/PDMR Shareholding
14th Oct 20222:30 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:30 pmRNSTotal Voting Rights
22nd Sep 20223:00 pmRNSDirector/PDMR Shareholding
20th Sep 202210:00 amRNSBlock listing Interim Review
16th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20223:00 pmRNSDirector/PDMR Shareholding
6th Sep 20224:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.